Serodiagnosis of Pulmonary Disease Due to Mycobacterium avium Complex Proven by Bronchial Wash Culture
To the Editor:
The diagnosis of Mycobacterium avium complex (MAC) pulmonary disease (MAC-PD) is often complicated and time consuming. MAC-PD is diagnosed according to the guidelines set forth by the American Thoracic Society in 2007, which include clinical and microbiologic criteria. 1 Bronchoscopy to obtain bronchial wash for a bacterial culture is often considered in patients in whom MAC-PD is diffi cult to diagnose by routine sputum examination; however, it is diffi cult to perform bronchoscopy in all patients. A novel approach to help diagnose such cases has been needed.
We previously reported the usefulness of a serodiagnostic test to determine serum IgA antibodies against a mycobacterial glycopeptidolipid (GPL) core for diagnosing MAC-PD proven by sputum culture. 2 -5 The present study was conducted to assess the accuracy of this test by comparing the results with bronchial wash cultures in patients with MAC-PD and negative sputum culture.
Bronchoscopy was performed in 56 patients suspected to have MAC-PD based on their symptoms and the presence of small nodular infi ltrates with bronchiectasis on chest CT scans. None of the patients were known to be seropositive for HIV. The results of the bronchial wash cultures were positive for MAC in 28 patients (50%), who then received a diagnosis of MAC-PD. The culture results were negative for MAC in the remaining one-half, who were assigned to the non-MAC disease group. The levels of serum IgA antibody against the GPL core antigen of MAC were measured using an enzyme immunoassay kit (TAUNS Laboratory Inc; Shizuoka, Japan) before bronchoscopy, and the values were compared between the two groups.
Serum IgA antibody levels to GPL core antigen were significantly higher in the MAC-PD group (5.0 6 4.7 UրmL) than in the non-MAC disease group (0.1 6 0.3 UրmL) ( P , .0001). With the cutoff value set at 0.7 UրmL according to a previous study, 5 the number of patients with seropositivity and seronegativity with or without MAC-PD is summarized in Table 1 . The sensitivity, specifi city, and positive and negative predictive values for diagnosing MAC-PD were 78.6%, 96.4%, 95.7%, and 81.8%, respectively.
In conclusion, the serodiagnostic test can accurately predict MAC positivity when compared with the results of bronchial wash cultures and may be safe and useful as an adjunct to diagnose MAC-PD. In particular, we consider that this approach may be useful in elderly patients for whom bronchoscopy cannot be performed because of other underlying conditions or in patients who are reluctant to undergo such an invasive procedure for very mild signs and symptoms. The levels of serum IgA antibody to GPL core antigen were signifi cantly higher in the MAC-PD group than in the non-MAC disease group ( P , .0001). The sensitivity and specifi city for diagnosing MAC-PD were 78.6% and 96.4%, respectively. GPL 5 glycopeptidolipid; MAC 5 Mycobacterium avium complex; MAC-PD 5 M avium complex pulmonary disease.
High Prevalence of Pseudomonas aeruginosa From Oropharyngeal Biofi lm in Patients With Cerebrovascular Infarction and Dysphagia

To the Editor:
Aspiration pneumonia develops after the aspiration of colonized oropharyngeal contents. 1 The elderly or patients with cerebrovascular disease (CVD) are often subjected to aspiration pneumonia because bacteria colonized in the oral cavity and oropharynx easily enter the lung during sleep and usually undergo repeated silent aspiration.
2 Aspiration pneumonia is increasing in patients with dysphagia, and aspiration pneumonia-associated mortality is a most serious problem in elderly patients. Interestingly, it has been reported that oral health care for elderly patients in nursing homes reduces bacterial pneumonia. 3 , 4 Therefore, it is very important to determine the characteristics of oropharyngeal microfl ora in patients with CVD to plan the optimum oral care to prevent aspiration pneumonia. From this standpoint, we investigated initial pharyngeal microfl ora in patients with CVD and dysphagia requiring daily nursing ( Table 1 ). This study protocol was approved by the Ethics Committee of Chikamori Rehabilitation Hospital. We collected swab samples from the oropharynx of 55 patients with CVD (26 with dysphagia and 29 without dysphagia). To count the colony-forming units, the swabs, which were diffused into sterile medium, were inoculated onto agar plate using the spiral system as described previously. 5 In addition to bacterial culture, polymerase chain reaction with bacterial-specifi c primers was used for bacterial identifi cation. A higher prevalence (38.5%; 10ր26) of Pseudomonas aeruginosa was observed in patients with CVD and dysphagia than in patients with CVD and without dysphagia (3.4%; 1ր29; P , .01). The prevalence of Staphylococcus spp (30.7% and 24.1%, respectively) and Candida spp (46.2% and 31.0%, respectively) in both groups was similar. Moreover, the bacterial number of P aeruginosa in patients with CVD and dysphagia was signifi cantly higher than in the group without dysphagia. Ten (47.6%) of 21 patients with CVD and dysphagia who needed complete or some assistance in daily living had P aeruginosa in their oropharyngeal microfl ora. Regarding the mode of nutritional intake, seven (63.6%) of 11 patients with CVD and dysphagia who were administered nutrition through a catheter had P aeruginosa in their oropharyngeal microfl ora. Interestingly, four (25%) of 16 patients with CVD and dysphagia whose test results were negative for P aeruginosa in oropharyngeal microfl ora were also administered nutrition through a catheter, and only one (3.4%) of 29 patients with CVD and without dysphagia had positive test results for P aeruginosa in oropharyngeal microfl ora. More importantly, these observations suggest that the high detection rate of P aeruginosa from oropharyngeal microfl ora in patients with CVD is increased by the status of dysphagia, not catheter use. Our data highlight that the care of oropharyngeal microfl ora, especially P aeruginosa , may be important to prevent aspiration pneumonia in patients with CVD and dysphagia. 
